Food and Nutrition Sciences
Vol. 3  No. 6 (2012) , Article ID: 19962 , 5 pages DOI:10.4236/fns.2012.36110

Occurrence of Enterobacter sakazakii (Cronobacter) and Other Enterobacteriaceae in Commercial Powdered Infant Formula in Abidjan, Ivory Coast

Kouadio Yao1,2, Nanga Yessé Zinzendorf2,3*, Guichard Bohoua1, Kra Athanase Kouassi1, Amian Koua4, Luc Kouakou Kouadio4,5, Patrice Kouamé1, Guillaume Yao Loukou2,3

1Department of Sciences and Food Technology, University of Abobo-Adjamé, Abidjan, Côte d’Ivoire; 2Department of Microbiology, National Laboratory of Public Health, Abidjan, Côte d’Ivoire; 3Department of Bacteriology and Virology, University of Cocody, Abidjan, Côte d’Ivoire; 4Deprtment of Hydrology and Public Health, University of Cocody, Abidjan, Côte d’Ivoire; 5Laboratory of Biology, National Institut of Public Health, Abidjan, Côte d’Ivoire.

Email: *nangatchocht@yahoo.fr

Received December 27th, 2011; revised May 3rd, 2012; accepted May 11th, 2012

Keywords: Enterobacteriaceae; Enterobacter sakazakii; Powedered Infant Formulat

ABSTRACT

To determine the occurrence of Enterobacter sakazakii and other Enerobateriaceae in commercial powdered infant formula (PIF), 185 packages of PIF from different manufacturers, supermarkets and drug-stores in Abidjan were analyzed. Ten g of sample was homogenized in 90 ml of buffered peptone water (PBW, Biorad, Paris) for further studies. Enterobacteriaceae (coliforms) were enumerated according to French Association of Standardization methods. E. sakazakii was detected according to Kandhai’s method. Bacteria were identified using API20 system. Thirty-eight samples (20.5%) were positive for Enterobacteriaceae. Twenty-four samples (13%) yielded Enterobacter sakazakii. Other Enterobacteriaceae isolated included Pantoea spp. 21 (11.5%), Klebsiella pneumoniae subsp. pneumoniae 8 (4.3%), Citrobacter diversus 1 (0.5%), Citrobacter freundii 1 (0.5%), Enterobacter cloacae 1 (0.5%), Salmonella reading 1 (0.5%), Serratia ficara 1 (0.5%) Serratia odorifera 1 (0.5%). This study is the first report to describe the contamination of PIF from Abidjan with E. sakazakii and several other Enterobacteriaceae that could be opportunistic pathogens. Therefore, well-controlled studies need to be conducted to assess the extent of risk associated with contaminated PIF for infants in Abidjan.

1. Background

Powdered Infant formula (PIF) is defined as powdered form specially manufactured and presented to be used by infants, either as beastmilk substitute after preparation with water or to modify prepared breastmilk substitutes or fortify human milk. PIF has been used to feed millions of infants for years, and it constitutes the majority of infant formula worldwidly used. This product is formulated to mimic the nutritional profile of human breast milk [1]. As PIF is not a sterile product, it is an excellent medium to support bacterial growth. Bovine milk is an essential ingredient of PIF and a potential source of bacteria that are pathogenic to humans. On occasion, bacterial pathogens have been cultured from PIF, including Citrobacter, Enterobacter, Klebsiella, Staphylococcus, Streptococcus, and Yersinia species. Should E. sakazakii multiply in PIF, it can result in infection [2]. A definitive link between the presence of E. sakazakii in an unopened can of PIF and an outbreak of infection has been reported [3]. Cases of invasive E. sakazakii infection have recently been added to the list of notifiable diseases in New Zealand, after the death of an infant due to E. sakazakii meningitis in July 2004 [4]. These actions highlight the importance of this opportunistic pathogen and the risk exposed to vulnerable infants.

The organism is ubiquitous in food products, being found in milk powder, rice, vegetables, cheese, sausage meat, teas, and various spices [5,6]. Moreover, E. sakazakii has been identified in the hospital environment in association with infant bottle brushes and food preparation equipment such as blenders [7]. However, most of the attention to E. sakazakii-related contamination of food products has focused on powdered infant formula.

According World Health Organization (OMS) and Food and Agricultural Organization (FAO), between 50 and 80% of PIF cases are the vehicle and the source of E. sakazakii-illness in the world [8]. In 2002, the US Food and Drug Administration (FDA) published a warning regarding the presence of E. sakazakii in baby formula [9]. In addition, there have been several recalls of formula in Asia, Europe, and North and South America as a result of E. sakazakii contamination [5,10,11]. This has resulted in increased efforts to implement appropriate strategies to reduce health risks associated with the use of PIF. In contrast, there is dearth information on contamination of PIF sold in Africa, particularly in Côte d’Ivoire. The aims of this study is to determine the occurrence of E. sakazakii and other Enterobacteriaceae in commercial PIF in Abidjan.

2. Material and Methods

2.1. Powered Infant formula (PIF) and Preparation of Inoculum

The PIF were purchased from supermarkets, drug-stores and food industries in Abidjan. Ten grammas of sample were homogenized in 90 ml of buffered peptone water (PBW, Biorad, Paris) for further studies. Each assay was repeated twice.

2.2. Enterobacteriaceae (Coliforms) Enumeration

Coliforms were enumerated according to AFNOR methods (NF V 08 015). Decimal dilutions (1 ml) of the food homogenate in BPW were used to inoculate Violet Red Bile Lactose agar (VRBLA, Biorad, Paris) using incurporation method. The plates were incubated at 30˚C for 24 h. On VRBLA coliforms form small red colonies (~0.5 mm diameter), with or without a red precipitate.

2.3. Identification of Enterobacteriaceae

Non-yellow colony types were identified using API20E (bioMérieux) to determine which of the Enterobacteriaceae were present in the sample after enrichment.

2.4. E. sakazakii Isolation and Identification

E. sakazakii isolation method was used according to Kandhai et al. [12]. Briefly, full homogenate in BPW was incubated for 20 h at 37˚C. One loofull was streaked on VRBGA (Biorad, Paris) from The overnight BPW broth and colony morphology observed after incubation at 37˚C for 24 h. Five red colonies were picked off and streaked on Trytone Soy Agar (TSA), (Biorad, Paris). Colonies that produced yellow pigment after incubation at 25˚C for 48 - 72 h were termed presumptive E. sakazakii. Non-yellow colony types were also picked. Presumptive colonies of E. sakazakii were tested for oxidase, using Oxidase DrySlide (Biorad, Paris). The oxidasenegative isolates were preliminary identified by α-glucosidase activity as described by Kandhai et al. [13]. α- glucosidase positive isolates were further identified using API 20 E test system (BioMérieux, SA, Marcy Etoile, France) and the corresponding identification software (ATB Expression version 6.0) using E. sakazakii ATCC 29544 as type strain.

2.5. Statistical Analyse

Descriptive statistical analyse was performed using Microsoft Office Excell program. The percentages were calculated on the basis of the total number of PIF analysed.

3. Results

A total of 185 PIF were analysed. Thirty-eight samples (20.5%) were positive for Enterobacter-iaceae. The distribution of Enterobacteriaceae detected was seen in Table 1. Twenty-four samples (13%) yielded E. sakazakii. Other Enterobacteriaceae isolated included Pantoea spp. 21 (11.5%), Klebsiella pneumoniae subsp. pneumoniae 8 (4.3%), Citrobacter diversus 1 (0.5%), Citrobacter freundii 1 (0.5%), Enterobacter cloacae 1 (0.5%), Salmonella reading 1 (0.5%), Serratia ficara 1 (0.5%) and Serratia odorifera 1 (0.5%). Within Enterobacteriaceae, coliforms were used as indicator of hygienic control in factory production lines. Microbiological specifications for coliform counts in PIF is <3 Colony Forming Unit/ gramma (CFU/g) of the current Codex code [5]. A total

Table 1. Distribution of powdered infant formula according to Enterobacteriaceae detected.

of 180 PIF were standard and 5 were no standard. E. sakazakii was detected in standard and no standard PIF respectively in 11.7% (21/180 and 60% (4/5) of cases (Table 2).

4. Discussion

To our knowledge, this is the first report to describe the contamination of dehydrated powdered infant formula in Ivory Coast with E. sakazakii and several other Enterobacteriaceae that could be opportunistic pathogens. Mutyjens and al showed that entrobacteriaceae were present in 52% of 141 different formulas from 35 countries [5]. In dehydrated powdered infant formula manufactured in Indonesia and Malaysia, Enterobacteriaceae were detected in 47% of the cases [14].

Cronobacter spp. have been repeatedly reported as remarkably resistant to osmotic stress and dryness and moderately thermotolerant as some encapsulated Cronobacter spp. were still recoverable from desiccated infant formula after storage for up to 2.5 years [15,16]. The composition of dry foods and infant formula combined with their low aw (ca. 0.2) significantly affected the survival of Cronobacter spp. in these foods [16-18]. With 13% of cases, E. sakazakii is the Enterobacteriacea more detected in food collected in Abidjan. These results are in accordance with those described by Estuningsih et al. [14]. In Jordan, Jaradat and al isolated E. sakazakii in 1.4% of infant’s foods [19].

According to microbial specifications for coliforms [5, 20], a total of 21 (11.7%) standard PIF were contaminated by E. sakazakii. The results obtained are agreed with the study of Muytens et al. [5]. who analysed 141 PIF from 13 countries and founded 20 positive culture, yet all met the microbiological specification counts in PIF. Such a formula has been linked to outbreaks [20].

Table 2. Distribution of Enterobacteriaceae detected in powdered infant formula according to microbial specifications for coliforms.

Iversen et al. 2004 [21] examined clinical and food strains and found that the generation times for E. sakazakii in reconstituted formula were 13.7 hours, 1.7 hours and 19 - 21 minutes at 6˚C, 21˚C and 37˚C respectively. Therefore, it is obvious that improper storage of contaminated reconstituted PIF can support rapid growth of E. sakazakii. Thus, low levels of contamination of E. sakazakii in PIF were considered to be a risk factor given potential for multiplication during the preparation and holding time prior to consumption of reconstituted formula. Now Ivory Coast is an underdeveloped country and characterized by a poor sanitary conditions. Risk reduction can be achieved by information and education about basic hygiene practices in connection with food handling, storage and preparation.

While E. sakazakii has caused disease in all the groups on the basis of the age distribution of reported cases, it was deduced that the group at particular risk is infants (i.e. children <1 year). Among infants, those who are immunocompromised and neonates (≤28 days) are considered to be a greatest risk, particularly neonates of low birth weight (<2500 g) [22]. Infants of HIV-positive mothers are also of concern, because they may specially require infant formula and they may be more susceptible to infection [23]. Ivory-Coast is characterized by a high proportion of special subpopulation consisting of lowbirth weight infants and infants of HIV-infected mothers [24]. In these circumstances the use of PIF may be increasing in Ivory Coast. To minimize the coast, Ivory Coast imports PIF from a few countries: for example from Indonesia and Malaysia where reports have shown that some batches of PIF are contaminated by E. sakazakii. For all considerations, well-controlled studies needs to be conducted to assess the extent of risk associated with contaminated PIF for infants in Ivory Coast.

In Ivory Coast, PIF are from very different origins. There are an official circuit and unofficial ones. The unofficial circuits are not controlled by the State administration and there are no data about them. And yet, the results showed were obtained from samples collected in the official distribution facilities. A study that takes into account all the PIF suppliers and a wider sample size is therefore helpful to assess the level of bacterial contaminations in PIF on the national scale. In addition, there are no data on E. sakazakii infections among newborn babies in Ivory Coast while the results obtained side with a contamination by PIF consumed in Abidjan. A distinctive emphasis should be put on research about E. sakazakii during infections among newborn babies under bottlefeeding. At the same time, a study should be conducted to assess the contamination by E. sakazakii in food dressed from PIF.

Cronobacter is often isolated from the environment in milk powder and PIF manufacturing facilities [25,26]. Pif contamination results from the introduction of the organism to the PIF at some stage during the manufacturing process. It is generally assumed that Cronobacter contamination of a product occurs in the processing environment at stages after pasteurization, including drying or packing. The prevalence of Cronobacter following the drying stage may be due (in part) to the ability of the organism to resist to drying or osmotic stress [27,28]. In Ivory Coast, commercial PIF were imported or produced locally. A total of 65 PIF were manufactured from Ivory Coast. All the isolates of E. sakazakii were detected in food produced locally, giving 36.9% of contaminated PIF. Studies conducted in Ivorian manufactures showed there is a default of hygiene in many food industries. Such reports may explain the prevalence of Cronobacter in PIF made in Ivory Coast [29]. The Ivorian infant food industry should be encouraged to reduce the concentration and prevalence of E. sakazakii in both the manufacturing environment and PIF. To this end, the infant food industry should consider implementing an effective environmental monitoring programme.

5. Conclusion

The results obtained showed an important level of PIF contaminated by E. sakazakii. Investigation and reporting of sources and vehicles, including PIF, of infection by E. sakazakii should be encouraged. This could include the establishment of laboratory-based network in Ivory Coast.

REFERENCES

  1. J. Breeuwer, A. Lardeau, M. Peterez and H. M. Joosten, “Desiccation and Heat Tolerance of Enterobacter sakazakii,” Journal of Applied Microbiology, Vol. 95, No. 5, 2003, pp. 967-973. doi:10.1046/j.1365-2672.2003.02067.x
  2. C. Agostoni, I. Axelsson, O. Goulet, B. Koletzko, K. F. Michaelsen, J. W. Puntis, J. Rigo R. Shamir, H. Szajewska, D. Turck, Y. Vandenplas, L. T. Weaver and ESPGHAN Committee on Nutrition, “Preparation and Handling of Powdered Infant Formula: A Commentary by the ESPGHAN Committee on Nutrition,” Journal of Pediatric and Gastroenterology Nutrition, Vol. 339, No. 4, 2004, pp. 320-322. doi:10.1097/00005176-200410000-00002
  3. Centers for Disease Control Prevention, “Enterobacter sakazakii Infections Associated with the Use of Powdered Infant Formula—Tennessee,” Morbidity and Mortality Weekly Reports, Vol. 51, No. 14, 2002, pp. 297-300.
  4. New Zealand Ministry of Health, “Enterobacter sakazakii,” 2010. http://www.moh.govt.nz/moh.nsf/0/526cb4a064b49a31cc257042007c4ef3?OpenDocument
  5. H. L. Muytjens, H. Roelofs-Willemse and G. H. J. Jasper, “Quality of Powdered Sustitues for Breast Milk with Regard to Members of the Family Enterobacteriaceae,” Journal of Clinical Microbiology, Vol. 26, No. 4, 1988, pp. 743-746.
  6. M. Friedemann, “Enterobacter sakazakii in Food and Beverages (Other than Infant Formula and Milk Powder),” International Journal of Food Microbiology, Vol. 116, No 1, 2007, pp. 1-10. doi:10.1016/j.ijfoodmicro.2006.12.018
  7. M. C. Kandhai, M. W. Reij, L. G. Gorris, O. GuillaumeGentil and M. van Schothorst, “Occurrence of Enterobacter sakazakii in Food Production Environments and Households,” Lancet, Vol. 363, No. 9402, 2004, pp. 39- 40. doi:10.1016/S0140-6736(03)15169-0
  8. F. R. Noriega, K. L. Kotloff, M. A. Martin and R. S. Schwalbe, “Nosocomial Bacteremia Caused by Enterobacter sakazakiki and Leuconostoc mesenteroides Resulting from Extrinsic Contamination of Infant Formula,” Pediatric Infection Disease Journal, Vol. 9, No. 6, 1990, pp. 447-449. doi:10.1097/00006454-199006000-00018
  9. United State Food and Drug Administration, “Isolation and Enumeration of Enterobacter sakazakii from Dehydrated Infantformula,” 2002. http://www.cfsanfdagov/∼comm/mmesakaz.html
  10. Food and Agricultural Organization/World Health Organization, “Enterobacter sakazakii and Microorganisms in Powdered Infant Formula,” 2005. http://www.apps.who.int/gb/ebwha/pdf
  11. J. van Acker, F. de Smet, G. Muyldermans, A. Bougatef, A. Naessens and S. Lauwers, “Outbreak of Necrotizing Enterocolitis Associated with Enterobacter sakazakii in Powdered Milk Formula,” Journal of Clinical Microbiology, Vol. 39, No. 1, 2001, pp. 293-297. doi:10.1128/JCM.39.1.293-297.2001
  12. M. C. Kandhai, M. W. Reij and L. G. M Gorris, “Occurrence of Enterobacter sakazakii in Food Production Environments and Households,” The Lancet, Vol. 363, No. 9402, 2004, pp. 39-40. doi:10.1016/S0140-6736(03)15169-0
  13. M. C. Kandhai, M. W. Reij, K. Van Puyveld, O. Guillaume-Gentil, R. R. Beumer and M. Van Schothorst, “A New Protocol for the Detection of Enterobacter sakazakii Applied to Environmental Samples,” Journal of Food Protection, Vol. 67, No. 6, 2004, pp. 1267-1270.
  14. S. Estuningsih, C. Kress, A. A. Hassan, O. Akineden, E. Schneider and E. Usleber, “Enterobacteriaceae in Dehydrated Powdered Infant Formula Manufactured in Indonesia and Malaysia,” Journal of Food Protection, Vol. 69, No. 12, 2006, pp. 3013-3017.
  15. J. C. Barron and S. J. Forsythe, “Dry Stress and Survival Time of Enterobacter sakazakii and Other Enterobacteriaceae in Dehydrated Powdered Infant Formula,” Journal of Food Protection, Vol. 70, No 9, 2007, pp. 2111- 2117.
  16. P. Breeuwer, A. Lardeau, M. Peterz and H. M. Joosten, “Desiccation and Heat Tolerance of Enterobacter sakazakii,” Journal of Applied Microbiology, Vol. 95, No. 5, 2003, pp. 967-973. doi:10.1046/j.1365-2672.2003.02067.x
  17. J. B. Gurtler and L. R. Beuchat, “Survival of Enterobacter sakazakii in Powdered Infant Formula as Affected by Composition, Water Activity, and Temperature,” Journal of Food Protection, Vol. 70, No. 7, 2007, pp. 1579- 1586.
  18. S. H. Kim and J. H. Park, “Thermal Resistance and Inactivation of Enterobacter sakazakii Isolates during Rehydration of Powdered Infant Formula,” Journal of Microbial and Biotechnology, Vol. 17, No. 2, 2007, pp. 364- 368.
  19. Z. W. Jaradat, Q. O. Ababneh, I. M. Saadoun, N. A. Samara and A. M. Rashdan, “Isolation of Cronobacter spp. (Formerly Enterobacter sakazakii) from Infant Food, Herbs and Environmental Samples and the Subsequent Identification and Confirmation of the Isolates Using Biochemical, Chromogenic Assays, PCR and 16S rRNA Sequencing,” BMC Microbiology, Vol. 9, No. 225, 2009. doi:10.1186/1471-2180-9-225
  20. J. van Acker, F. de Smet, G. Muyldermans, A. Bougatef, A. Naessens and S. Lauwers, “Outbreak of Necrotizing Enterocolitis Associated with Enterobacter sakazakii in Powdered Milk Formula,” Journal of Clinical Microbiology, Vol. 39, No. 1, 2001, pp. 293-297. doi:10.1128/JCM.39.1.293-297.2001
  21. C. Iversen, M. Lane and S. J. Forsythe, “The Growth Profile, Thermotolerance and Biofilm Formation of Enterobacter sakazakii Grown in Infant Formula Milk,” Letters in Applied Microbiology, Vol. 38, No. 5, 2004, pp. 378-382. doi:10.1111/j.1472-765X.2004.01507.x
  22. World Health Organization, “Mother-Baby Package: Implementing Safe Motherhood in Countries,” 1994. http://www.who.int/maternal_child_adolescent/documents/who_dhe_msm_9411/en/index.html
  23. World Health Organization, “New Data on the Prevention of Mother-to-Child Transmission of HIV and Their Policy Implications: Conclusions and Recommendations,” 2001. http://whqlibdoc.who.int/hq/2001/WHO_RHR_01.28.pdf
  24. République de Côte d’Ivoire/Ministère de la Santé et de l’Hygiène Publique, “Plan national de développement stratégique 2009-2013,” 2012. www.mshp-ci.com
  25. D. Drudy, M. O’Rourke, M. Murphy, N. R. Mullane, R. O’Mahony, L. Kelly, M. Fischer, S. Sanjaq, P. Shannon, P. Wall, M. O’Mahony, P. Whyte and S. Fanning, “Characterization of a Collection of Enterobacter sakazakii Isolates from Environmental and Food Sources,” International Journal of Food Microbiology, Vol. 110, No. 2, 2006, pp. 127-134. doi:10.1016/j.ijfoodmicro.2006.02.008
  26. M. C. Kandhai, M. W. Reij, L. G. Gorris, O. GuillaumeGentil and M. van Schothorst, “Occurrence of Enterobacter sakazakii in Food Production Environments and Households,” Lancet, Vol. 363, No. 9402, 2004, pp. 39- 40. doi:10.1016/S0140-6736(03)15169-0
  27. B. Arku, N. Mullane, E. Fox, S. Fanning and K. Jordan, “Enterobacter sakazakii Survives Spray Drying,” International Journal of Dairy Technology, Vol. 61, No. 1, 2008, pp. 102-108. doi:10.1111/j.1471-0307.2008.00375.x
  28. P. Breeuwer, A. Lardeau, M. Peterz and H. M. Joosten, “Desiccation and Heat Tolerance of Enterobacter sakazakii,” Journal of Applied Microbiology, Vol. 95, No. 5, 2003, pp. 967-973. doi:10.1046/j.1365-2672.2003.02067.x
  29. S. C. Yoro, B. A. Naoufal, A. Koua, A. N’Gbakoua and M. Dosso, “Surveillance de l’Hygiène des Employés des Manufactures de Traitement des Produits Alimentaires à Abidjan (Côte d’Ivoire) de 1990 à 1995,” Microbiologie et Hygiène Alimentaire, Vol. 15, No. 42, 2003, pp. 15-18.

NOTES

*Corresponding author.